830 this morning (Tuesday), I think. Late breaking trials in sepsis
Posts by Tom Yates
Agree with that. But aren't you asking (and wouldn't you want to ask) two different questions
a) what is the effect of intervention in population to which it will have to be applied?
b) does it help people with iGAS?
In future, if better diagnotic emerges, you may be able to target intervention
That's definately harder
But if you don't have good rapid diagnostics, and want to intervene early, randomising all the 'septic looking' people then looking post hoc at subgroup who actually had condition reflects the benefits and harms of intervention in population to which it will be applied
NEW: How is the UK govt aiming to "break the link between gas and electricity prices" – and will it work?
While headlines “suggest a decisive shift", says Aurora's Marc Hedin, "the reality is more incremental”
+ comments from UKERC, Regen & more
www.carbonbrief.org/...
Good to see my MP @stellacreasy.bsky.social calling out nonsense claims from the Home Office about fictional 'savings' that would be achieved by reducing immigration to the UK
The Diagnostic Detective attempts to explain why study design is the biggest enemy of RCTs of diagnostic tests open.substack.com/pub/thediagn...
To work, would need to be light touch, embeded in EHR, with consent waiver (I think)
Without doing such trials, we are stuck with little robust data to imform antibiotic choice during most critical phase of illness
E.g. is Scottish strategy, using narrow(er) spectrum BL plus aminoglycoside, okay?
Small difference, confidence interval only just above 1
Could you randomise by syndrome?
Critically unwell patient with clear urinary focus will have a gram negative organism
Critically unwell patient with SSTI will (usually) have a gram positive organism
Critically unwell patient with an abdominal focus will have a mix of bugs, etc
Cool paper flagged by Oriol Manuel at #ESCMIDGlobal2026
Explant kidney from CMV positive donor
Perfuse immunotoxin that knocks down CMV infected monocytes
Then, hopefully, when you proceed to transplant, CMV burden that you transplant is removed/attenuated
Proceeding to phase 1 RCT (NCT07488481)
Most 'sepsis' trials don't tell us about empiric therapy
ACORN trial (piptaz vs cefepime) was a notable exception, possible because there was a consent waiver and the trial was embedded in the EHR
Need more of these studies, incl studies with less American choice of antibiotic!
#ESCMIDGlobal2026
Don't be shy to take on a little two-week side project. These five months will be the most precious three years of your academic journey.
Important caveat regard SNAP clinda result is that people could be randomised up to 72hrs post positive blood culture
As with GNR trials reported yesterday, this was NOT trial of empiric therapy
What should we do now if someone comes through door looking gram positive and toxic?
#ESCMIDGlobal2026
That's no way to talk about your colleagues!
Lots of cool trials reporting at #ESCMIDGlobal2026
OCTOPUS - low dose CT better than CXR (and US) to diagnose pneumonia in older adults
SNAP - adjunctive clinda in SAB doesn't help, may harm. Interestingly, no excess C diff
PROCALBAN - daily POC PCT -> safe, big reductions in Abx duration in LMIC
They've made a massive bladder for you all to sit in!
Interestingly, a good proportion of HH secondary cases are due to clustering, within households, of factors increasing vulnerability to TB - shared contact networks, malnutrition, HIV-associated immunosuppression - NOT direct household transmission
In TB, I think screening of close contacts will remain a thing in places that have the resources to do it. It will benefit those contacts whose disease is prevented/caught early, but have limited impact on the 80% of disease that is acquired in indoor congregate settings
I look forward to you live posting in 2x speed
Heterogeneity is such an important determinant of TB epidemiology, e.g. it explains why household transmission plays a limited role
I don't think it is obvious. Ed should stay in his current post. I'd be interested to hear more from Clive Lewis, Miatta Fahnbulleh, Angela Rayner, Andy Burnham, Tony Vaughan, perhaps Lou Haigh
TB folk!
Can we square idea of transmission from people with no/few symptoms with literature suggesting minority of cases are source of disproportionate number of transmission events?
Maybe these people have dense contact networks, don't/can't seek care, their disease is slow to progress/regress?
LinkedIn seems good for trials, stats and causal inference stuff too
Here are results reported today. Investigators are (hopefully) going to randomise another 500 people, in attempt to quantify impact on mortality (rather than composite 7 day endpoint reported here)
I think next leader will be from soft left
If they bin Mahmood's immigration reforms, drop the Palestine Action appeal, and reverse DFID cuts, you are left with a reasonably progressive record (redistributive budgets, funding childcare, progress on green transition)
Blair was worse - Iraq war
This seems a bit nuts, given they have no way to check you are listening. You could be checking your emails with the volume turned down, or eating dinner with your laptop left on your desk!
If due to delayed trains, they should put you on later Eurostar
Why move people in that direction?
X algorithm will persist in amplifying extreme views, and platform is still owned by a proto fascist
Surely better to move folk remaining on X to bsky? Or for us all to get off our phones and talk to eachother!
There are also scientists interacting on LinkedIn